MedPath

Medicinal use of ozonated olive oil and triamcinolone acetonide in oral ulcers.

Phase 4
Conditions
Health Condition 1: K137- Other and unspecified lesions of oral mucosa
Registration Number
CTRI/2024/06/069274
Lead Sponsor
Shreeya Panchal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects in age group 14-70 years.

Subjects having one or more recurrent ulcers.

Subjects having duration of ulcer not more than 48 hours.

Subjects should not be on any medication for oral ulcers.

Subjects with painful ulcers causing discomfort.

Subjects should be healthy, with no systemic disease (diabetes) and immune-deficiency state.

Exclusion Criteria

Patients suffering from systemic disorders which are known to cause ulcerations.

Patients who are already undergoing therapy for aphthous ulcers.

Patients presenting with chronic non-healing ulcers.

Patients reporting of ‘no pain/painless ulcer’.

Patients suffering from oral submucous fibrosis.

Pregnant women or lactating mothers.

Patient having known history of serious drug hypersensitivities.

Patients unable to attend multiple visits.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath